InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: TheExpertHimself post# 75691

Sunday, 05/17/2015 2:30:36 PM

Sunday, May 17, 2015 2:30:36 PM

Post# of 80868
In 2009, the Bank of America stock ran up from $3 to $18....so whenever speculators think that things have changed, they look at no fundamentals whatsoever.

The outlook provided by Musclepharm's management is very bullish, and the eventual Capstone Nutrition acquisition is something that might be considered bullish by some as well, considering that Post Holdings paid $380 million for Dymatize with $140 million revenue...meaning Musclepharm should become a plus $200 million company net of debt if it acquires Capstone Nutrition.

Concerns about large stock grants might vanish entirely if the management delivers unreal results....I would like to see some good results and some solid stock price appreciation before I feel obligated to credit the management for anything though. I'm not particularly pleased with anything the management has delivered thus far.